Omega Fund Management, LLC
- SEC CIK
- 0001637359
- Latest filing
- Aug 14, 2026
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Nov 15, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 23
- −1 vs. Q1 2021
- Portfolio value
- $883.6M
- −$173.6M (−16.4%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| NUVBNuvation Bio Inc. | COM CL A | 28,212,376 | $262.7M | 29.7% | 00.0% | Unchanged | History |
| REPLReplimune Group, Inc. | COM | 5,008,245 | $192.4M | 21.8% | 00.0% | Unchanged | History |
| MORFMorphic Holding, Inc. | COM | 1,767,350 | $101.4M | 11.5% | −505,128−22.2% | Reduced | History |
| KRONKronos Bio, Inc. | COM | 3,818,283 | $91.4M | 10.3% | 00.0% | Unchanged | History |
| IMAImageneBio, Inc. | COM | 2,249,123 | $31.6M | 3.6% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 3,320,608 | $27.0M | 3.1% | 00.0% | Unchanged | History |
| SPRBSpruce Biosciences, Inc. | COM | 2,161,022 | $24.2M | 2.7% | 00.0% | Unchanged | History |
| IMUXImmunic, Inc. | COM | 1,788,160 | $21.9M | 2.5% | 00.0% | Unchanged | History |
| PRTKParatek Pharmaceuticals, Inc. | COM | 2,600,410 | $17.7M | 2.0% | 00.0% | Unchanged | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 623,836 | $17.0M | 1.9% | 00.0% | Unchanged | History |
| SANASana Biotechnology, Inc. | COM | 843,750 | $16.6M | 1.9% | 00.0% | Unchanged | History |
| AVIRAtea Pharmaceuticals, Inc. | COM | 746,868 | $16.0M | 1.8% | −100,340−11.8% | Reduced | History |
| SYRSSyros Pharmaceuticals, Inc. | COM | 2,274,831 | $12.4M | 1.4% | +712,331+45.6% | Added | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,284,900 | $11.6M | 1.3% | 00.0% | Unchanged | History |
| EPIXESSA Pharma Inc. | COM NEW | 328,196 | $9.38M | 1.1% | −8,673−2.6% | Reduced | History |
| CMPICheckmate Pharmaceuticals, Inc. | COM | 1,335,050 | $7.96M | 0.9% | 00.0% | Unchanged | History |
| Omega Alpha SpacG6749V107 | CL A | 501,000 | $4.99M | 0.6% | 00.0% | Unchanged | – |
| CDTXCidara Therapeutics, Inc. | COM | 2,005,249 | $4.05M | 0.5% | 00.0% | Unchanged | History |
| KYNBKyntra Bio, Inc. | COM | 130,646 | $3.48M | 0.4% | 00.0% | Unchanged | History |
| OBSVObsEva SA | COM | 999,364 | $3.03M | 0.3% | 00.0% | Unchanged | History |
| TRVITrevi Therapeutics, Inc. | COM | 1,263,408 | $2.84M | 0.3% | 00.0% | Unchanged | History |
| IMCRImmunocore Holdings plc | ADS | 51,535 | $2.01M | 0.2% | 00.0% | Unchanged | History |
| JNCEJounce Therapeutics, Inc. | COM | 275,513 | $1.87M | 0.2% | 00.0% | Unchanged | History |
Sold out since Q1 2021 (1)
Positions held at the end of Q1 2021 that are gone from this filing.
| Security | Class | Shares in Q1 2021 | Value in Q1 2021 | % of portfolio in Q1 2021 | History |
|---|---|---|---|---|---|
| Pieris Pharmaceuticals Inc720795103 | COM | 225,741 | $580.0K | 0.1% | – |